Erratum: Patterns of drug use during a 15 year period: Data from a Swedish county 1988-2002 (Pharmacoepidemiology and Drug Safety (2005) vol. 11 (813-820) 10.1002/pds.1124);Patterns of drug use during a 15 year period: Data from a Swedish county, 1988-2002

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 11, 2005, Pages 813-820

  Silwer, Louise ^a,c   Lundborg, Cecilia Stålsby ^a,b  

^a Apoteket AB   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIANEMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC AGENT; CENTRAL STIMULANT AGENT; DIURETIC AGENT; ESTRADIOL; ESTRIOL; ESTROGEN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT; RESPIRATORY TRACT AGENT; SEX HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DRUG USE; EXPOSURE; FEMALE; GROUPS BY AGE; HORMONE SUBSTITUTION; HUMAN; INFANT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PEPTIC ULCER; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT COURSE THERAPY; SWEDEN; SYMPTOM;

EID: 28044456968     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1426     Document Type: Erratum

References (28)

1. Lindberg G, Hallas J. Cholesterol-lowering drugs and antidepressants - a study of prescription symmetry. Pharmacoepidemiol Drug Safe 1998; 7: 399-402.
2. Gram LE, Hallas J, Andersen M. Pharmacovigilance based on prescription databases. Pharmacol Toxicol 2000; 86: 13-15.
3. Miller E, Blatman B, Einarson TR. A survey of population-based drug databases in Canada. CMAJ 1996; 154: 1855-1864.
4. Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother 1996; 30: 589-595.
5. West SL, Savitz DA, Koch G, et al. Demographics, health behaviours and past drug use as predictors of recall accuracy for previous prescription medication use. J Clin Epidemiol 1997; 50: 975-980.
6. Klungel OH, de Boer A, Paes AH, et al. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000; 53: 273-277.
7. Neutel CI, Walop W. Comparing two different approaches to measuring drug use within the same survey. Chronic Dis Can 2000; 21: 150-156.
8. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Safe 2002; 11: 379-384.
9. Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM. Comparison of indicators assessing the quality of drug prescribing for asthma. Health Serv Res 2001; 36: 143-161.
10. National Corporation of Swedish Pharmacies (Apoteket AB). Swedish Drug Statistics. National Drug Sales Statistics: Miscellaneous Statistics and Diagnosis and Therapy Survey. Apoteket AB: Stockholm, 2000.
11. Socialstyrelsen (The national board of health and welfare). Hälso-och sjukvårdsstatistisk årsbok 2002 (Yearbook of Health and Medical Care 2002) tab. 1.4. p 75 http://www.sos.se (0311)
12. World Health Organization Collaborating Centre for Drug Statistics Methodolgy. Introduction to Drug Utilization Research. WHO: Oslo, 2003; 14.
13. Silwer L, Johansson E, Sålsby Lundborg C. Drug prescribing in public primary care centres - results from prescription studies 1988-1997 in the country of Halland, Sweden. Scand J Prim Health Care 2002; 20: 236-241.
14. Silwer L, Stålsby Lundborg C. Drug prescribing in primary care related to patient age-trends in a ten-year repeated prescription study in a Swedish province. Eur J Gen Pract 2005; 11: 23.
15. WHO Collaborating Centre for Drugs Statistics Methodology. ATC Index With DDD. Oslo, Norway, 2002.
16. Statistics Sweden (SCB). Population statistics. 2003. http://www.scb.se. (0402).
17. Baigi A, Högstedt B, Odén A, et al. Life expectancy in the province of Halland, Sweden, 1911-1950: the progress of public health in a long-living population. Scand J Public Health 2002; 30: 231-237.
18. Socialstyrelsen (The national board of health and welfare). Läkemedel i användning - förändringar och tendenser Kvartalsrapport 2001:1 p 44. (Drugs in use-changes and trends). http://www.sos.se (0311).
19. National Corporation of Swedish Pharmacies (Apoteket AB). Läkemedel i Sverige (Drug sales, Sweden). Apoteket AB 2005. http://www.apoteket.se/apoteket (0502).
20. Werkö L, Bergkvist L, Bixo M, et al. SBU-rapport: Behandling med östrogen (report from the National committee on medical evaluation. Hormone replacement therapy). Stockholm, 2002. http://www.sbu.se (0402).
21. Hopkins Tanne J. Oestrogen only arm of women's health initiative trial is stopped. Br Med J 2004; 328: 602.
22. Atkinson S, Atkinson MJ, Tarrant AM. Estrogens from sewage in coastal marine environments. Environ Health Perspect 2003; 111: A232.
23. Jobling S, Casey D, Rodgers-Gray T, et al. Comparative responses of molluscs and fish to environmental estrogens and an estrogenic effluent. Aquat Toxicol 2003; 65: 205-220.
24. Mc Caig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287: 3096-3102.
25. Nasjonalt folkehelseinstitutt (Norwegian institute of public health) Ökende forbruk av forebyggende hjertemedisiner (Increased use of preventive cardiovascular treatments). 2004. http://www.fhi.no (0402).
26. Socialstyrelsen (The national board of health and welfare). Hälso-och sjukvårdsstatistisk årsbok 2002 (Yearbook of Health and Medical Care 2002). 1.1, tab.7 http://www.sos.se (0311).
27. Gasse C, Stieber J, Doting A, et al. Population trends in antihypertensive drug use: results from the MONICA Augsburg project 1984-1995. J Clin Epidemiol 1999; 52: 695-703.
28. Socialstyrelsen (The national board of health and welfare). Läkemedel i användning - förändringar och tendenser Kvartalsrapport 2002:3 p 41. (Drugs in use - changes and trends). http://www.sos.se (0311).